MARANDA MILES: Open Payments
NPI 1679062731 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,470 in 18 payments from 10 companies in 2025. Trend: 2023 $598 · 2024 $672 · 2025 $1,470
Food & beverage: $1,470
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $375 |
| Novo Nordisk Inc | 3 | $260 |
| Amgen Inc. | 2 | $160 |
| Madrigal Pharmaceuticals | 1 | $150 |
| ABBVIE INC. | 2 | $142 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| ABIOMED | 1 | $108 |
| Exact Sciences Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Wegovy, REZDIFFRA, TAVNEOS, QULIPTA, FANAPT, AIRSUPRA, BREZTRI, JARDIANCE.
Industry payments across KY — which companies pay providers there.
